Table 2.
Process measures during the study period
| Standard of care (N = 42) | Intervention (N = 45) | P value | Intracluster correlation coefficient | |
|---|---|---|---|---|
| VTE prophylaxis ordered | 0.86 | 0.427 | ||
| Not done | 7 (17) | 15 (33) | ||
| Within 48 hr | 28 (68) | 27 (60) | ||
| 48 hr | 6 (15) | 3 (7) | ||
| VTE prophylaxis administered | 0.42 | 0.000 | ||
| Not done | 1 (3) | 0 (0) | ||
| Within 48 hr | 27 (79) | 27 (90) | ||
| After 48 hr | 6 (18) | 3 (10) | ||
| C. difficile testing | 0.64 | 0.013 | ||
| Not done | 2 (5) | 3 (6) | ||
| Within 48 hr | 39 (93) | 42 (93) | ||
| After 48 hr | 1 (2) | 0 (0) | ||
| Flexible sigmoidoscopy | 0.41 | 0.000 | ||
| Not done | 5 (12) | 10(22) | ||
| Within 48 hr | 31 (74) | 28 (62) | ||
| After 48 hr | 6 (14) | 7 (16) | ||
| Cytomegalovirus biopsies during flexible sigmoidoscopy | 0.52 | 0.158 | ||
| Not done | 2 (5) | 0 (0) | ||
| Done | 35 (95) | 35 (100) | ||
| TB skin testing | 0.13 | 0.000 | ||
| Not done | 18 (43) | 22 (50) | ||
| Within 48 hr | 11 (26) | 19 (43) | ||
| After 48 hr | 13 (31) | 3 (7) | ||
| Hepatitis B serology | 0.44 | 0.063 | ||
| Not done | 17 (40) | 12 (27) | ||
| Within 48 hr | 20 (48) | 31 (69) | ||
| After 48 hr | 5 (12) | 2 (4) |